Selective endothelin B receptor blockade does not influence BNP-induced natriuresis in man

Kidney International

Volumn 69, Issue 5, 2006, Pages 864-868

  Van Der Zander, K ^a,d   Houben, A J H M ^a,c   Webb, D J ^b   Udo, E ^a   Kietselaer, B ^a   Hofstra, L ^a   De Mey, G R ^a   De Leeuw, P W ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNILEVER RESEARCH VLAARDINGEN   (Netherlands)

Author keywords

Brain natriuretic peptide; Endothelin receptor antagonist; Hemodynamics; Natriuresis; Renal function; Vasoconstriction dilatation

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CYCLIC GMP; ENDOTHELIN 1; ENDOTHELIN B RECEPTOR; ENDOTHELIN B RECEPTOR ANTAGONIST; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; PLACEBO;

4 AMINOHIPPURIC ACID CLEARANCE; ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; CONTROLLED STUDY; DIURESIS; DRUG INFUSION; ELECTROCARDIOGRAM; FUNCTIONAL PROTEOMICS; GLOMERULUS FILTRATION RATE; HEART OUTPUT; HEART RATE; HUMAN; HUMAN EXPERIMENT; INULIN CLEARANCE; KIDNEY BLOOD FLOW; KIDNEY PLASMA FLOW; NATRIURESIS; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RECEPTOR BLOCKING; RECEPTOR INTRINSIC ACTIVITY; SIGNAL TRANSDUCTION;

CROSS-OVER STUDIES; CYCLIC GMP; DOUBLE-BLIND METHOD; ENDOTHELIN-1; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; INFUSIONS, INTRAVENOUS; KIDNEY; MALE; MIDDLE AGED; NATRIURESIS; NATRIURETIC PEPTIDE, BRAIN; OLIGOPEPTIDES; PIPERIDINES; RECEPTOR, ENDOTHELIN B;

EID: 33644501867     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ki.5000215     Document Type: Article

References (22)

1. La Villa G, Stefani L, Lazzeri C et al. Acute effects of physiological increments of brain natriuretic peptide in humans. Hypertension 1995; 26: 628-633.
2. van der Zander K, Houben AJ, Kroon AA et al. Does brain natriuretic peptide have a direct renal effect in human hypertensives? Hypertension 2003; 41: 119-123.
3. De Feo ML, La Villa G, Lazzeri C et al. Urinary endothelin-1 excretion is enhanced by low-dose infusion of brain natriuretic peptide in normal humans. Hypertension 1997; 29: 70-74.
4. Nitta K, Naruse M, Sanaka T et al. Natriuretic and diuretic effects of endothelin in isolated perfused rat kidney. Endocrinol Jpn 1989; 36: 887-890.
5. Sakurai T, Yanagisawa M, Takuwa Y et al. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 1990; 348: 732-735.
6. Arai H, Hori S, Aramori I et al. Cloning and expression of a cDNA encoding an endothelin receptor. Nature 1990; 348: 730-732.
7. Gray GA, Webb DJ. The endothelin system and its potential as a therapeutic target in cardiovascular disease. Pharmacol Ther 1996; 72: 109-148.
8. van der Zander K, Houben AJ, Kroon AA et al. Nitric oxide and potassium channels are involved in brain natriuretic peptide induced vasodilatation in man. J Hypertens 2002; 20: 493-499.
9. Harris PJ, Zhuo J, Mendelsohn FA, Skinner SL. Haemodynamic and renal tubular effects of low doses of endothelin in anaesthetized rats. J Physiol 1991; 433: 25-39.
10. Clavell AL, Stingo AJ, Margulies KB et al. Role of endothelin receptor subtypes in the in vivo regulation of renal function. Am J Physiol 1995; 268: F455-F460.
11. Goddard J, Johnston NR, Hand MF et al. Endothelin-A receptor antagonism reduces blood pressure and increases renal blood flow in hypertensive patients with chronic renal failure: a comparison of selective and combined endothelin receptor blockade. Circulation 2004; 109: 1186-1193.
12. Honing ML, Hijmering ML, Ballard DE et al. Selective ET(A) receptor antagonism with ABT-627 attenuates all renal effects of endothelin in humans. J Am Soc Nephrol 2000; 11: 1498-1504.
13. Vuurmans JL, Boer P, Koomans HA. Effects of endothelin-1 and endothelin-1-receptor blockade on renal function in humans. Nephrol Dial Transplant 2004; 19: 2742-2746.
14. Houben AJ, van der Zander K, de Leeuw PW. Vascular and renal actions of brain natriuretic peptide in man: physiology and pharmacology. Fundam Clin Pharmacol 2005; 19: 411-419.
15. Marin-Grez M, Fleming JT, Steinhausen M. Atrial natriuretic peptide causes pre-glomerular vasodilatation and post-glomerular vasoconstriction in rat kidney. Nature 1986; 324: 473-476.
16. Fried TA, McCoy RN, Osgood RW, Stein JH. Effect of atriopeptin II on determinants of glomerular filtration rate in the in vitro perfused dog glomerulus. Am J Physiol 1986; 250: F1119-F1122.
17. Stockand JD, Sansom SC. Regulation of filtration rate by glomerular mesangial cells in health and diabetic renal disease. Am J Kidney Dis 1997; 29: 971-981.
18. Strachan FE, Spratt JC, Wilkinson IB et al. Systemic blockade of the endothelin-B receptor increases peripheral vascular resistance in healthy men. Hypertension 1999; 33: 581-585.
19. Goddard J, Webb DJ. Endothelin antagonists and hypertension: a question of dose? Hypertension 2002; 40: e1-e2; author reply e1-e2.
20. World Medical Association Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. Cardiovasc Res 1997; 35: 2-3.
21. van der Zander K, Houben AJ, Hofstra L et al. Hemodynamic and renal effects of low-dose brain natriuretic peptide infusion in humans: a randomized, placebo-controlled crossover study. Am J Physiol Heart Circ Physiol 2003; 285: H1206-H1212.
22. Cole BR, Giangiacomo J, Ingelfinger JR, Robson AM. Measurement of renal function without urine collection. A critical evaluation of the constant-infusion technique for determination of inulin and para-aminohippurate. N Engl J Med 1972; 287: 1109-1114.